Cargando…
Comparison of Clinical Characteristics and Outcomes Between Community-Acquired and Healthcare-Associated Bacteremia Cases due to Bacteroides Species
BACKGROUND: Differences in clinical characteristics and outcomes between community-acquired (CA) and healthcare-associated (HCA) Bacteroides bacteremia cases are not well known. METHODS: We evaluated all positive blood cultures between March 2012 and December 2016 in a Japanese 781-bed acute hospita...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632262/ http://dx.doi.org/10.1093/ofid/ofx163.334 |
_version_ | 1783269665115471872 |
---|---|
author | Ando, Naokatsu Hayakawa, Kayoko Katanami, Yuichi Mezaki, Kazuhisa Takaya, Saho Yamamoto, Kei Takeshita, Nozomi Kutsuna, Satoshi Ohmagari, Norio |
author_facet | Ando, Naokatsu Hayakawa, Kayoko Katanami, Yuichi Mezaki, Kazuhisa Takaya, Saho Yamamoto, Kei Takeshita, Nozomi Kutsuna, Satoshi Ohmagari, Norio |
author_sort | Ando, Naokatsu |
collection | PubMed |
description | BACKGROUND: Differences in clinical characteristics and outcomes between community-acquired (CA) and healthcare-associated (HCA) Bacteroides bacteremia cases are not well known. METHODS: We evaluated all positive blood cultures between March 2012 and December 2016 in a Japanese 781-bed acute hospital. Identification and susceptibility was performed based on CLSI criteria, and MALDI-TOF has been used since January 2015 in addition to conventional methods. RESULTS: Of 3611 bacteremia cases, 266 (7.4%) were due to obligately anaerobic bacteria, such as Clostridium species (n = 97 [36.5%]), Fusobacterium species (15 [7.5%]), and Bacteroides species (65 [24.4%]), of which 31 (47.7%) were HCA and 34 (52.3%) were CA. In 22 (33.8%) cases, > 2 blood cultures were positive. B. fragilis was most frequently isolated (n = 25 [38.5%]), then B. thetaiotaomicron (n = 9 [13.8%]), B. vulgatus (n = 5, [7.7%]), B. uniformis (n = 3 [4.6%]), B. distasonis (n = 2 [3.1%]), B. ureolyticus (n = 2 [3.1%]), B. capillosus (n = 1 [1.5%]), and B. ovatus (n = 1 [1.5%]). After introducing MALDI-TOF, the number of unidentified Bacteroides species fell from 12 (18.5%) to 5 (7.7%). Sensitivity to ampicillin/sulbactam, cefmetazole, and clindamycin was 85.2%, 92.6%, and 59.3%, respectively. Most bacteremia (51 [78.5%]) were of intra-abdominal origin. Baseline characteristics and immunocompromised status of HCA and CA Bacteroides bacteremia patients were similar, except for diabetes, which was more frequent in HCA cases (Table). There was significantly higher 7- and 30-day mortality in HCA than in CA cases (P = 0.03). CONCLUSION: The higher mortality in HCA Bacteroides bacteremia suggests the need for appropriate multidisciplinary management of these cases. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-5632262 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-56322622017-10-12 Comparison of Clinical Characteristics and Outcomes Between Community-Acquired and Healthcare-Associated Bacteremia Cases due to Bacteroides Species Ando, Naokatsu Hayakawa, Kayoko Katanami, Yuichi Mezaki, Kazuhisa Takaya, Saho Yamamoto, Kei Takeshita, Nozomi Kutsuna, Satoshi Ohmagari, Norio Open Forum Infect Dis Abstracts BACKGROUND: Differences in clinical characteristics and outcomes between community-acquired (CA) and healthcare-associated (HCA) Bacteroides bacteremia cases are not well known. METHODS: We evaluated all positive blood cultures between March 2012 and December 2016 in a Japanese 781-bed acute hospital. Identification and susceptibility was performed based on CLSI criteria, and MALDI-TOF has been used since January 2015 in addition to conventional methods. RESULTS: Of 3611 bacteremia cases, 266 (7.4%) were due to obligately anaerobic bacteria, such as Clostridium species (n = 97 [36.5%]), Fusobacterium species (15 [7.5%]), and Bacteroides species (65 [24.4%]), of which 31 (47.7%) were HCA and 34 (52.3%) were CA. In 22 (33.8%) cases, > 2 blood cultures were positive. B. fragilis was most frequently isolated (n = 25 [38.5%]), then B. thetaiotaomicron (n = 9 [13.8%]), B. vulgatus (n = 5, [7.7%]), B. uniformis (n = 3 [4.6%]), B. distasonis (n = 2 [3.1%]), B. ureolyticus (n = 2 [3.1%]), B. capillosus (n = 1 [1.5%]), and B. ovatus (n = 1 [1.5%]). After introducing MALDI-TOF, the number of unidentified Bacteroides species fell from 12 (18.5%) to 5 (7.7%). Sensitivity to ampicillin/sulbactam, cefmetazole, and clindamycin was 85.2%, 92.6%, and 59.3%, respectively. Most bacteremia (51 [78.5%]) were of intra-abdominal origin. Baseline characteristics and immunocompromised status of HCA and CA Bacteroides bacteremia patients were similar, except for diabetes, which was more frequent in HCA cases (Table). There was significantly higher 7- and 30-day mortality in HCA than in CA cases (P = 0.03). CONCLUSION: The higher mortality in HCA Bacteroides bacteremia suggests the need for appropriate multidisciplinary management of these cases. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5632262/ http://dx.doi.org/10.1093/ofid/ofx163.334 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Ando, Naokatsu Hayakawa, Kayoko Katanami, Yuichi Mezaki, Kazuhisa Takaya, Saho Yamamoto, Kei Takeshita, Nozomi Kutsuna, Satoshi Ohmagari, Norio Comparison of Clinical Characteristics and Outcomes Between Community-Acquired and Healthcare-Associated Bacteremia Cases due to Bacteroides Species |
title | Comparison of Clinical Characteristics and Outcomes Between Community-Acquired and Healthcare-Associated Bacteremia Cases due to Bacteroides Species |
title_full | Comparison of Clinical Characteristics and Outcomes Between Community-Acquired and Healthcare-Associated Bacteremia Cases due to Bacteroides Species |
title_fullStr | Comparison of Clinical Characteristics and Outcomes Between Community-Acquired and Healthcare-Associated Bacteremia Cases due to Bacteroides Species |
title_full_unstemmed | Comparison of Clinical Characteristics and Outcomes Between Community-Acquired and Healthcare-Associated Bacteremia Cases due to Bacteroides Species |
title_short | Comparison of Clinical Characteristics and Outcomes Between Community-Acquired and Healthcare-Associated Bacteremia Cases due to Bacteroides Species |
title_sort | comparison of clinical characteristics and outcomes between community-acquired and healthcare-associated bacteremia cases due to bacteroides species |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632262/ http://dx.doi.org/10.1093/ofid/ofx163.334 |
work_keys_str_mv | AT andonaokatsu comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies AT hayakawakayoko comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies AT katanamiyuichi comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies AT mezakikazuhisa comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies AT takayasaho comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies AT yamamotokei comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies AT takeshitanozomi comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies AT kutsunasatoshi comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies AT ohmagarinorio comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies |